Drugs that contain Clarithromycin
1. Biaxin Xl patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6010718 | ABBVIE | Extended release formulations of erythromycin derivatives |
Apr, 2017
(7 years ago) | |
| US6551616 | ABBVIE | Extended release formulations of erythromycin derivatives |
Jul, 2017
(6 years ago) | |
Market Authorisation Date: 03 March, 2000
Treatment: Treatment of mild to moderate infection caused by susceptible strains
Dosage: TABLET, EXTENDED RELEASE;ORAL
How can I launch a generic of BIAXIN XL before it's drug patent expiration?
More Information on Dosage
BIAXIN XL family patents
